Oppenheimer analyst Jeff Jones maintained a Buy rating on Immunocore Holdings (IMCR – Research Report) today and set a price target of $87.00. The company’s shares closed last Friday at $48.98.

Goldman Sachs analyst Rajan Sharma has maintained their bullish stance on IMCR stock, giving a Buy rating yesterday. Rajan Sharma has given his Buy rating due to a combination of factors that ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Immunocore Holdings PLC - ADR’s current stock price and volume Why Immunocore Holdings PLC - ADR’s stock price changed recently Upgrades and downgrades for IMCR from analysts IMCR’s stock price ...

IMCR stock is trading at a margin of -9.84%, -14.81% and -16.39% apart from the 20-Day, 50-Day and 200-Day Simple Moving Average prices. 3 Tiny Stocks Primed to Explode The world's greatest investor — ...

After hours: May 10 at 4:00 PM EDT ...

Immunocore Holdings Plc (NASDAQ: IMCR) has released the latest phase 1 data on brenetafusp (IMC-F106C), an off-the-shelf IMTAC targeting PRAME for the treatment of late-line cutaneous melanoma. As of ...

After hours: June 5 at 6:41 PM EDT Loading Chart for IMTX ...

Sifting through countless of stocks in the Pharmaceuticals industry can be tedious, and sometimes two stocks are just too similar to judge which is the better investment. If you’re on the fence about ...